Last reviewed · How we verify
NCT05227885
The Effects of Nutritional on Disease Activity and Functional Status in RA
trial testing questionnaire form in Rheumatoid Arthritis in 100 participants. Completed in 31 May 2022.
29 April 2022
Quick facts
| Lead sponsor | Balikesir University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 100 |
| Start date | 20 December 2021 |
| Primary completion | 29 April 2022 |
| Estimated completion | 31 May 2022 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- questionnaire form
Conditions studied
- Rheumatoid Arthritis — all drugs for Rheumatoid Arthritis →
Sponsor
Balikesir University
Who can join
Adults 18 to 75, any sex, with Rheumatoid Arthritis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Rheumatoid arthritis (RA) is a chronic, autoimmune, systemic, inflammatory disease. RA is a chronic inflammatory disease in which many patients cannot achieve remission despite current pharmacological treatments. Chronic inflammation in RA causes an increase in metabolic index and nutritional requirements. In recent studies, it is mentioned that diet regimens and foods consumed in nutrition affect inflammation. The aim of this study is to evaluate the nutritional status and habits of patients with RA and to examine their effects on disease activity level, quality of life and functional status. A questionnaire form will be applied to collect data on demographic information, disease activity, nutritional status and habits, physical activity status and physical functional status of the patients included in the study.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Effects of Nutritional Status and Foods Consumed on Inflammation and Disease Activity in Patients with Rheumatoid Arthritis.
Uysal B, Sahin N, Kara H. · · 2024 · cited 3× · PMID 39202479 · DOI 10.3390/medicina60081197
Verify or expand the search:
- PubMed search for NCT05227885
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Rheumatoid Arthritis
Currently open trials in the same condition.
- NCT07433335 — A Study to Assess the Safety and Tolerability of SR-878 in Patients With Rheumatoid Arthritis · Phase 1 · recruiting
- NCT07491016 — Efficacy and Safety of Telitacicept Combined With Baricitinib for Refractory Rheumatoid Arthritis · recruiting
- NCT07171983 — A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-986454 in Participants With Rheumatoid Arthritis · Phase 1 · recruiting
- NCT07246096 — Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA U CAR-T Cell Injection for the Treatment of Rel · EARLY_PHASE1 · recruiting
- NCT07363590 — A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004) · Phase 1 · recruiting
Other Balikesir University trials
Trials by the same sponsor.
- NCT07048093 — Development of Standard Guidelines for Relaxation Exercises in Patients With Chronic Neck Pain and Determination of Thei · NA · not yet recruiting
- NCT06812481 — Anticholinergic Burden and Osteoporosis in Rheumatoid Arthritis · recruiting
- NCT06856395 — Effect of Using Educational Robots During Vaccination on Fear and Pain in Children · NA · not yet recruiting
- NCT07103837 — Development, Validity, and Reliability of the Reactive Skill Test in Older Adults · NA · completed
- NCT07203924 — Prognostic Importance of Physical Activity in Geriatric Patients With Acute Coronary Syndrome · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05227885 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Balikesir University
- Last refreshed: 8 February 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05227885.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing